Loading
Journal of Mental Health Disorders
ISSN: 2770-761X
Volume 1, Issue 2, p36-60
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
The Loneliness, Loss and Reflections Set off by COVID-19
“Nothing was as it seemed. I was not as I seemed…I was confronted by the possibility that perhaps the truest thing about me was a coiled identity, my irrealis self, a might-have-been self that never really was but wasn’t unreal for not being and might still be real, though I feared it never would”
J Ment Health Disord, 2021, Volume 1, Issue 2, p36-40 | DOI: 10.33696/mentalhealth.1.006Biomedical Gastronomy in the Management of Smell and Taste Disorders
Whether one lives to eat or just eats to live, the consumption, ingestion and digestion of foods and beverages comprise a complex system of intertwined signals and rituals.
J Ment Health Disord, 2021, Volume 1, Issue 2, p41-44 | DOI: 10.33696/mentalhealth.1.007A New Adaptive Procedure for Estimating Perceptual Thresholds: The Effects of Observer Bias and Its Correction
Perceptual thresholds might vary due to different variables such as fatigue, fluctuations of attention, or sensory learning [1]. Adaptive threshold estimation procedures are most effective by providing quasi-instantaneous estimates of an otherwise fluctuating sensory threshold.
J Ment Health Disord, 2021, Volume 1, Issue 2, p45-58 | DOI: 10.33696/mentalhealth.1.008Clinical Supervision: Getting It Right!
The article ‘Enablers and barriers to effective clinical supervision in the workplace: a rapid evidence review’ presents evidence from the international literature on effective clinical supervision. The review searched nearly 16000 international publications to answer the question: What makes effective clinical supervision? When in place and done well, clinical supervision has many benefits for the organisation, professional development and patient services.
J Ment Health Disord, 2021, Volume 1, Issue 2, p59-60 | DOI: 10.33696/mentalhealth.1.009COVID-19 Clinical Research
While the global COVID-19 pandemic has challenged the entire humanity and health systems, it also triggered researchers to urgently perform clinical trials to assess the safety and efficacy of many agents and modalities to combat COVID-19. As of April 22, over 650 clinical studies have been registered both in USA and internationally. Results from these studies are also coming at a brisk pace in this unprecedented emergency.
Therapeutic Values of Ketamine for COVID-19-Cared Patients: An Expert’s Point of View
Ketamine has long been used in the field of anesthesia [1]. Its rapid and long-acting analgesic effects associated with its dissociative properties have also established its use in prehospital and emergency department patients.
A Bioinformatics Protocol for Rational Design of Peptide Vaccines and the COVID-19 Rampage
The currently ongoing coronavirus pandemic, the SARSCOV- 2, interchangeably referred to as the COVID-19 infection, has in a short span of time altered the ways and means of almost all of mankind. So strong has been its effect that all human activity ceased in one way or another for a considerable time, led to significant loss of life and economic drain of.
Lessons Learnt from COVID-19: How Can We Prepare for Another Pandemic?
Five months into the COVID-19 pandemic, the U.S. death toll from the virus has now surpassed 100,000 people. Many more cases remain nationwide, while an unknown number of patients currently harbor the virus asymptomatically. While health officials are now optimistic regarding the decline in prevalence and number of deaths due to COVID-19 and the possibility of a vaccine by the fall, we cannot lose sight of the bigger picture: the next pandemic.
Safety of Using Rituximab Therapy During COVID-19 Pandemic
Rituximab is a chimeric (20% rodent and 80% human) monoclonal antibody that binds to the CD20 antigen present on the cell surface and leads to depletion of mature B-cells [1,2]. It is the first approved monoclonal antibody to be used in the therapy of indolent B-cell non- Hodgkin’s lymphoma and chronic lymphocytic leukemia
Educators as Essential Workers in the Era of COVID-19: Applying Lessons from Disaster Recovery
In the article, “Mental Health Framework: Coronavirus pandemic in post-Katrina New Orleans” [1], Shervington and Richardson offer recommendations about how to anticipate and address disaster-related, trauma exposures associated with the coronavirus pandemic
How Well Do Hemodialysis Patients Respond to the BNT162b2 mRNA COVID-19 Vaccine?
In January 2020, the World Health Organization (WHO) classified COVID-19 to be a Public Health Emergency of International Concern and declared it a pandemic on March 11, 2020 [1]. Over one hundred and eighty-five million people have been infected by SARS-CoV-2 and roughly four million have died worldwide so far
Healthy Fetal Outcomes Using A Novel Treatment For Maternal Lyme Disease And Babesiosis During Consecutive Pregnancies: A Case Study and Literature Review
The genus Babesia comprises over 100 species of tick-transmitted protozoal intraerythrocytic pathogens (piroplasms) [1], causing malarial-type illness. The most common human pathogens in the United States are B. microti [2] and Babesia duncani (WA- 1) [3]; Less common species include Babesia MO-1 [4] and KO-1 [5], as well as Babesia divergens and Babesia venatorum (EU-1) in Europe.
Metabolic Syndrome is an Important Cornerstone in the Health-disease Line and Pathological Organ Interaction
Today, metabolic syndrome (MS) has been regarded as a very important disease due to its complex multifactorial etiology and damage to different organs. In general, obesity, dyslipidemia, hypertension, hyperglycemia, and insulin resistance are the main metabolic abnormalities of the MS. Compared with the others; in particular, insulin resistance and central obesity are considered the main causes in the pathogenesis
Machine Learning for Healthcare: Emerging Challenges and Opportunities in Disease Diagnosis
Diagnosis is a process that identifies, explains, or establishes the individual’s disease from its symptoms and signs. Early and precise diagnosis is crucial since it influences the efficacy of treatment and avoids longterm complications for the infected person. Further, in the case of infectious diseases, undiagnosed patients can transmit the disease to a healthy population unknowingly. Besides, most of the diseases evolve with the time that significantly affects the clinical outcomes.
Using Mitochondrial Trifunctional Protein Deficiency to Understand Maternal Health
Fatty acid oxidation disorders unfortunately can result in the sudden unexplained death of infants. Mitochondrial trifunctional protein (MTP) deficiency is one such disease where long-chain fatty acids cannot be fully oxidized through beta-oxidation which, can lead to cardiac arrythmias in an infant.
Predicting COVID-19 Hospitalized Patients’ Outcome with Homocysteine
The COVID-19 pandemic has provoked a global, rapid increase of cases due to the high infectivity of the etiological agent, COVID-19 virus. In February 2021, over 110 million confirmed COVID-19 cases with 1 million deaths were reported worldwide (www.who.int).
Recommendation of Tetanus Toxoid Vaccination for Pregnant Females in a Country that Achieved Elimination of Maternal and Neonatal Tetanus. A commentary on the Study: Knowledge and Health Beliefs of Reproductive-age Women in Alexandria about Tetanus Toxoid Immunization
The study “knowledge and health beliefs of reproductive-age women in Alexandria about tetanus toxoid immunization” has shed a new light on the attitude of obstetricians in Alexandria (Egypt) towards recommending tetanus toxoid vaccination to pregnant females.
Dexamethasone: The First Drug to be Shown to Decrease Mortality in Critically Ill Patients with COVID-19
The precise role of corticosteroids for treatment of coronavirus disease 2019 (COVID-19) is unclear due to lack of randomized trials.
How to Prevent Rehospitalization in Patients with COVID-19
Since December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) caused by 2019 Novel Coronavirus (2019-nCoV) has resulted in 89,000 cases of Corona Virus Disease 2019 (COVID-19), formerly known as Novel Coronavirus Pneumonia (NCP) in China, including 2,450 deaths.
Classical Drug and its New Role in COVID-19 Management
COVID-19 is the new emerging viral infection that already cause global public health problem [1-3]. More than 220 countries/territories are already attacked and there are more than 17 million patients around the world
Preparing for a More Public Health-Aware Practice of Medicine in Response to COVID-19
After one year in a pandemic, we mourn the loss of over half a million lives in the United States, and over four million worldwide, and remain concerned over the challenges facing the families of 35 million people in the United States, and 200 million worldwide, who have suffered from cases of COVID-19.
Quantifying Respiratory Airborne Particle Dispersion Control Through Improvised Reusable Masks: The Physics of Non-Pharmaceutical Interventions for Reducing SARS-CoV-2 (COVID-19) Airborne Transmission
In light of the current pandemic from rapid transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) and significant morbidity, there has been inconsistent medical guidance given to the public regarding the wearing of non-medical improvised fabric masks or face coverings to reduce the transmission of COVID-19.
The Use of Hydroxychloroquine and Interferons for the Prophylaxis of COVID-19
At the beginning of Covid-19 pandemic, we proposed to use hydroxychloroquine (HCQ) and intranasal interferon (IFN) a-2b spray to prevent SARS-CoV-2.
Rehabilitation Providers’ Experiences with Rapid Telerehabilitation Implementation During the COVID-19 Pandemic in the United States
Telehealth has been around since the 1960s as a healthcare delivery modality, though it did not gain widespread acceptance as a viable and reliable clinical tool until the late 1990s, when digital imaging and high speed, high bandwidth telecommunications technology became widely available [1]. Historical boundaries to its acceptance and
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.